cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Guardant Health Inc
21 own
7 watching
Current Price
$32.39
$0.38
(1.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
3,317.18M
52-Week High
52-Week High
78.34
52-Week Low
52-Week Low
24.63
Average Volume
Average Volume
2.94M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization3,317.18M
icon52-Week High78.34
icon52-Week Low24.63
iconAverage Volume2.94M
iconDividend Yield--
iconP/E Ratio--
What does the Guardant Health Inc do?
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.
Read More
How much money does Guardant Health Inc make?
News & Events about Guardant Health Inc.
Business Wire
1day ago
Guardant Health Inc. (Nasdaq: GH), a leading precision oncology company, and AnHeart Therapeutics, a clinical-stage global biopharmaceutical company committed to developing novel precision oncology therapeutics, announced today a strategic collaboration on the development, regulatory approval and...
Business Wire
4days ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved its Guardant360 CDx liquid biopsy test as a companion diagnostic to identify advanced or metastatic breast cancer patients with ESR1 mutations who...
Business Wire
15days ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, is partnering with The Royal Marsden NHS Foundation Trust on Part C of its Tracking mutations in cell free DNA to predict Relapse in eArly Colorectal Cancer (TRACC) study, which will evaluate the use of circulating tumor DNA...
Business Wire
1month ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. Guardant Healths management is scheduled to present and participate in a Q&A session on Monday, January...
Business Wire
1month ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Susan G. Komen, the worlds leading breast cancer organization, announced today that they have entered into a partnership to bring the patient perspective to the development of clinical studies that help identify...
Frequently Asked Questions
Frequently Asked Questions
What is Guardant Health Inc share price today?
plus_minus_icon
Can Indians buy Guardant Health Inc shares?
plus_minus_icon
How can I buy Guardant Health Inc shares from India?
plus_minus_icon
Can Fractional shares of Guardant Health Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Guardant Health Inc stocks?
plus_minus_icon
What is today’s traded volume of Guardant Health Inc?
plus_minus_icon
What is today’s market capitalisation of Guardant Health Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Guardant Health Inc?
plus_minus_icon
What percentage is Guardant Health Inc down from its 52-Week High?
plus_minus_icon
What percentage is Guardant Health Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$32.39
$0.38
(1.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00